| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Absolute lymphocyte count proliferation kinetics after CAR T-cell infusion impact response and relapse
|
Faude, Sophia
|
|
|
5 |
8 |
p. 2128-2136
|
artikel
|
| 2 |
Activated IL-6 signaling contributes to the pathogenesis of, and is a novel therapeutic target for, CALR-mutated MPNs
|
Balliu, Manjola
|
|
|
5 |
8 |
p. 2184-2195
|
artikel
|
| 3 |
Activity of blinatumomab in lymphoblastic leukemia with impaired T-cell immunity due to congenital immunodeficiency
|
Ramdeny, Sandheeah
|
|
|
5 |
8 |
p. 2153-2155
|
artikel
|
| 4 |
A novel differentiation response with combination IDH inhibitor and intensive induction therapy for AML
|
Mason, Emily F.
|
|
|
5 |
8 |
p. 2279-2283
|
artikel
|
| 5 |
Can palliative care consultation increase integration of palliative care for patients with hematologic malignancies?
|
Prod'homme, Chloé
|
|
|
5 |
8 |
p. 2123-2127
|
artikel
|
| 6 |
Caplacizumab prevents refractoriness and mortality in acquired thrombotic thrombocytopenic purpura: integrated analysis
|
Peyvandi, Flora
|
|
|
5 |
8 |
p. 2137-2141
|
artikel
|
| 7 |
Cedazuridine/decitabine: from preclinical to clinical development in myeloid malignancies
|
Patel, Anand A.
|
|
|
5 |
8 |
p. 2264-2271
|
artikel
|
| 8 |
Characteristics, complications, and sites of bleeding among infants and toddlers less than 2 years of age with VWD
|
Dupervil, Brandi
|
|
|
5 |
8 |
p. 2079-2086
|
artikel
|
| 9 |
Clinical, molecular, and prognostic comparisons between CCUS and lower-risk MDS: a study of 187 molecularly annotated patients
|
Li, Marissa
|
|
|
5 |
8 |
p. 2272-2278
|
artikel
|
| 10 |
Editorial Board
|
|
|
|
5 |
8 |
p. i
|
artikel
|
| 11 |
Effect of lisocabtagene maraleucel on HRQoL and symptom severity in relapsed/refractory large B-cell lymphoma
|
Patrick, Donald L.
|
|
|
5 |
8 |
p. 2245-2255
|
artikel
|
| 12 |
Efficacy and safety of prophylactic high-dose MTX in high-risk DLBCL: a treatment intent–based analysis
|
Jeong, Hyehyun
|
|
|
5 |
8 |
p. 2142-2152
|
artikel
|
| 13 |
Extended thromboprophylaxis for medically ill patients with cancer: a systemic review and meta-analysis
|
Osataphan, Soravis
|
|
|
5 |
8 |
p. 2055-2062
|
artikel
|
| 14 |
IGVL gene region usage correlates with distinct clinical presentation in IgM vs non-IgM light chain amyloidosis
|
Sidana, Surbhi
|
|
|
5 |
8 |
p. 2101-2105
|
artikel
|
| 15 |
Impact of splicing mutations in acute myeloid leukemia treated with hypomethylating agents combined with venetoclax
|
Lachowiez, Curtis A.
|
|
|
5 |
8 |
p. 2173-2183
|
artikel
|
| 16 |
Infection-related morbidity and mortality among older patients with DLBCL treated with full- or attenuated-dose R-CHOP
|
Eyre, Toby A.
|
|
|
5 |
8 |
p. 2229-2236
|
artikel
|
| 17 |
Inhibiting autophagy targets human leukemic stem cells and hypoxic AML blasts by disrupting mitochondrial homeostasis
|
Dykstra, Kaitlyn M.
|
|
|
5 |
8 |
p. 2087-2100
|
artikel
|
| 18 |
Lenalidomide triggers T-cell effector functions in vivo in patients with follicular lymphoma
|
Ménard, Cédric
|
|
|
5 |
8 |
p. 2063-2074
|
artikel
|
| 19 |
Oxidized mitochondrial DNA released after inflammasome activation is a disease biomarker for myelodysplastic syndromes
|
Ward, Grace A.
|
|
|
5 |
8 |
p. 2216-2228
|
artikel
|
| 20 |
Potent preclinical activity of HexaBody-DR5/DR5 in relapsed and/or refractory multiple myeloma
|
van der Horst, Hilma J.
|
|
|
5 |
8 |
p. 2165-2172
|
artikel
|
| 21 |
Preclinical activity and determinants of response of the GPRC5DxCD3 bispecific antibody talquetamab in multiple myeloma
|
Verkleij, Christie P.M.
|
|
|
5 |
8 |
p. 2196-2215
|
artikel
|
| 22 |
Prevalence, predictors, and outcomes of clonal hematopoiesis in individuals aged ≥80 years
|
van Zeventer, Isabelle A.
|
|
|
5 |
8 |
p. 2115-2122
|
artikel
|
| 23 |
13q12.2 deletions and FLT3 overexpression in acute leukemias
|
Poubel, Caroline Pires
|
|
|
5 |
8 |
p. 2075-2078
|
artikel
|
| 24 |
Single-center experience with venetoclax combinations in patients with newly diagnosed and relapsed AML evolving from MPNs
|
Masarova, Lucia
|
|
|
5 |
8 |
p. 2156-2164
|
artikel
|
| 25 |
Systematic review and meta-analysis of outcomes in patients with suspected pulmonary embolism
|
Patel, Parth
|
|
|
5 |
8 |
p. 2237-2244
|
artikel
|
| 26 |
Transplant-associated thrombotic microangiopathy in pediatric patients: pre-HSCT risk stratification and prophylaxis
|
Higham, Christine S.
|
|
|
5 |
8 |
p. 2106-2114
|
artikel
|
| 27 |
Treating lymphoma is now a bit EZ-er
|
Morin, Ryan D.
|
|
|
5 |
8 |
p. 2256-2263
|
artikel
|
Tijdschrift beschrijving